Novo Nordisk
NVO
535 hedge funds and large institutions have $10.7B invested in Novo Nordisk in 2016 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 147 increasing their positions, 234 reducing their positions, and 63 closing their positions.
12% more call options, than puts
Call options by funds: $26.7M | Put options by funds: $23.9M
0.58% less ownership
Funds ownership: 19.64% → 19.07% (-0.58%)
2% less funds holding
Funds holding: 548 → 535 (-13)
9% less capital invested
Capital invested by funds: $11.7B → $10.7B (-$1.06B)
14% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 63
34% less funds holding in top 10
Funds holding in top 10: 38 → 25 (-13)
37% less repeat investments, than reductions
Existing positions increased: 147 | Existing positions reduced: 234
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$47.9M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$32.3M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$32.2M |
| 4 |
WCM Investment Management
Laguna Beach,
California
|
+$26.9M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$26.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$268M |
| 2 |
HL
Harding Loevner
Bridgewater,
New Jersey
|
-$103M |
| 3 |
WI
WBI Investments
Red Bank,
New Jersey
|
-$27.6M |
| 4 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$20M |
| 5 |
OCAM
Onex Canada Asset Management
Toronto,
Ontario, Canada
|
-$19.1M |
NVO Hedge Fund Activity: Q1 2016 in Review
535 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q1 2016, worth a combined $10.7B — down 9% from $11.7B a quarter earlier.
Sellers outnumbered buyers: 63 funds closed out of NVO and 54 opened new positions — a net loss of 9 holders — while 234 trimmed existing stakes and 147 added.
The largest buyer was Loomis, Sayles & Company, adding an estimated $47.9M. The largest seller was Arrowstreet Capital, cutting an estimated $268M.
- 535 institutional investors held Novo Nordisk (NVO) as of Q1 2016, down from 548 in Q4 2015.
- Funds reported $10.7B of Novo Nordisk stock for Q1 2016, down 9% quarter-over-quarter.
- 54 funds opened new Novo Nordisk positions in Q1 2016 and 63 closed out, a net change of -9 holders.
- The largest Novo Nordisk buyer in Q1 2016 was Loomis, Sayles & Company, an estimated $47.9M added.
- The largest Novo Nordisk seller in Q1 2016 was Arrowstreet Capital, an estimated $268M sold.
Based on aggregated 13F filings for Q1 2016.